Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

SEI Investments declares $0.52 per share dividend payable June 16, 2026

Company Fundamentals
27 May 2026
Prnewswire
View Source
Bullish
pluang ai news

SEI Investments Company announced a regular semi-annual dividend of $0.52 per share. The dividend will be paid to shareholders of record as of June 8, 2026, with the payment scheduled for June 16, 2026. SEI is a major financial technology and asset management firm managing about $1.9 trillion in assets as of March 31, 2026. This dividend reflects SEI's ongoing commitment to returning value to its shareholders.

More News

Global GLP-1 receptor agonist market to reach $95.3B by 2035, growing at 12.1% CAGR driven by diabetes and obesity demand.

Global GLP-1 receptor agonist market to reach $95.3B by 2035, growing at 12.1% CAGR driven by diabetes and obesity demand.

The global GLP-1 receptor agonist market, used primarily for type 2 diabetes and obesity management, is projected to grow from $28.7 billion in 2025 to $95.3 billion by 2035, at a compound annual growth rate of 12.1%. Growth is fueled by rising diabe...

Market News
Bullish
3 hours ago
17EdTech Q1 2026 revenue jumps 359%, net loss narrows to RMB19.4M on AI-driven growth

17EdTech Q1 2026 revenue jumps 359%, net loss narrows to RMB19.4M on AI-driven growth

17 Education & Technology Group Inc. reported a strong first quarter for 2026 with net revenues soaring 359% year-over-year to RMB99.5 million, driven by its AI-powered personalized learning app Yiqi Aixue. The company improved its gross margin to 61...

Company Fundamentals
Bullish
3 hours ago
Lawsuit alleges Corcept Therapeutics hid FDA concerns about key drug approval risks

Lawsuit alleges Corcept Therapeutics hid FDA concerns about key drug approval risks

Kuehn Law is investigating Corcept Therapeutics for allegedly failing to disclose FDA concerns about the clinical development of relacorilant, a drug candidate for Cushing's syndrome. The lawsuit claims Corcept misled shareholders by promoting expect...

Market News
Bearish
4 hours ago
Investigation launched into Simulations Plus for possible false statements affecting investors.

Investigation launched into Simulations Plus for possible false statements affecting investors.

The Schall Law Firm is investigating Simulations Plus, Inc. for potentially issuing false or misleading statements and failing to disclose important information to investors. This probe could impact shareholders who may have suffered losses due to th...

Market News
Bearish
4 hours ago
Bitcoin's key use is rebuilding global finance, says Michael Saylor, beyond just payments.

Bitcoin's key use is rebuilding global finance, says Michael Saylor, beyond just payments.

Michael Saylor, Executive Chairman of Strategy, explained that bitcoin's most significant role is not just as a payment method but as the foundation for global money, credit, and capital markets. He envisions BTC-backed financial products offering yi...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App